-
Cheryl Freeman, material transfer specialist in the Office of the Vice President for Research, is UAB’s Employee of the Month for September.
-
Researchers will delve into the role of inflammation and the immune system in the worsening of Parkinson’s disease as UAB is named a Udall Center of Excellence.
-
UAB was part of a national, multisite study that showed a drug for multiple sclerosis was effective in slowing down brain atrophy, or shrinkage.
-
UAB will fill a gap in the stroke belt as it joins StrokeNet, a national research consortium.
-
The goal is an early warning system to block incipient seizures for patients where medications have failed.
-
Four medical specialties are ranked in the top 20 in the nation, and six more are ranked in the top 50.
-
Investigators note that the use of CBD oil led to both fewer and less intense seizures for patients with intractable epilepsy in landmark study.
-
UAB research suggests protein misfolding, perhaps caused by a reduction in a regulatory protein, could be associated with Parkinson’s disease.
-
With electronic-cigarette use on the rise, doctoral student Abdullah Alanazi and Eric Ford, Ph.D., professor in the School of Public Health, want to understand the trend’s relationship with drug use — and is using UAB’s informatics framework for translational research to do it.
-
There’s no evidence-based consensus on how long a seizure-ridden patient should be kept in an artificial coma to enable the brain to recover. Wolfgang Muhlhofer, M.D., an assistant professor of neurology, wants to change that.
